Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
Rajasree Nair, Shannon B MossBaylor Family Medicine Residency at Garland, Garland, Texas, USAAbstract: Attention-deficit hyperactivity disorder (ADHD) is one of the most common psychiatric disorders in young adults and causes significant psychosocial impairment and economic burden to society. Becaus...
Guardado en:
Autores principales: | Rajasree Nair, Shannon B Moss |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/086fb5806e554daea70147c9a831d154 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study
por: Valdizán-Usón JR, et al.
Publicado: (2013) -
Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
por: Jan K Buitelaar, et al.
Publicado: (2009) -
Treatment of adults with attention-deficit/hyperactivity disorder
por: Dusan Kolar, et al.
Publicado: (2008) -
Treatment of adults with attention-deficit/hyperactivity disorder
por: Dusan Kolar, et al.
Publicado: (2008) -
A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder
por: Maneeton N, et al.
Publicado: (2014)